# Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer

> **NCT03127007** · PHASE1,PHASE2 · COMPLETED · sponsor: **Grand Hôpital de Charleroi** · enrollment: 45 (actual)

## Conditions studied

- Rectal Neoplasms

## Interventions

- **DRUG:** Atezolizumab
- **DRUG:** 5-FU based radio-chemotherapy

## Key facts

- **NCT ID:** NCT03127007
- **Lead sponsor:** Grand Hôpital de Charleroi
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-27
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-10-15
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127007, "Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03127007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*